Home » Topics » Conferences

Conferences
RSS

Selective protein kinase C beta antagonist discovered by Lilly

April 12, 1996

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

COX-2 inhibitor reported by Searle

April 12, 1996

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 9, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave
BioWorld MedTech
Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...